News for Marker Therapeutics, Inc. (MRKR)

Published at

May 19, 2025 4:00 PM

by gurufocus.com

positive

positive

Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies

Virtual event with Key Opinion Leaders to discuss cell therapy landscape and shortcomings of CAR-T therapies set for May 28, 2025 HOUSTON, May 19, 2025 (GLO

VERA MRKR

Read more →
Published at

May 19, 2025 3:18 PM

by gurufocus.com

positive

positive

Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies | MRKR Stock News

Marker Therapeutics (MRKR) to present at a virtual panel discussing CD19 CAR-T cell therapies on May 28, 2025. The company will showcase its MAR-T cell

MRKR

Read more →
Published at

Mar 5, 2025 6:24 PM

by benzinga.com

positive

positive

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Abeona Therapeutics (NASDAQ:ABEO), Fluence Energy (NASDAQ:FLNC)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

MRKR KRYS ABEO 0H7R.L

Read more →
Published at

Feb 25, 2025 2:00 PM

by gurufocus.com

neutral

neutral

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

HOUSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. ( MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation

MRKR

Read more →
Published at

Feb 15, 2025 12:08 PM

by gurufocus.com

positive

positive

Blue Owl Capital Holdings LP Acquires Shares in Marker Therapeutics Inc

On December 31, 2024, Blue Owl Capital Holdings LP (Trades, Portfolio) made a significant move by acquiring 554,250 shares of Marker Therapeutics Inc (MRKR). Th

PLRX OWL MRKR

Read more →
Published at

Feb 15, 2025 11:20 AM

by gurufocus.com

positive

positive

Alyeska Investment Group's Strategic Acquisition in Marker Therapeutics Inc

Overview of the Recent Transaction On December 31, 2024, Alyeska Investment Group, L.P. (Trades, Portfolio) executed a significant transaction by acquiring 1,06

MRKR ADBE34.SA ADBE.MX ADBE ADB.DE

Read more →
Published at

Dec 19, 2024 2:14 PM

by manilatimes.net

positive

positive

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

**media[496596]**

MRKR

Read more →
Published at

Dec 18, 2024 2:11 PM

by rttnews.com

mixed

mixed

Pre-market Movers: PLRZ, VSTE, PRZO, NUKK, VRAR…

Israel-based Polyrizon Ltd. (PLRZ) is up over 217 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

TMCI PTGEF PRTG ATXI SKYT NUKK NOTV MRKR AMPGW AMPG 0HN9.L

Read more →
Published at

Dec 17, 2024 2:33 PM

by seekingalpha.com

positive

positive

Marker Therapeutics pops on receiving $9.5M grant to advance lead asset (NASDAQ:MRKR)

Marker Therapeutics (MRKR) shares surged 11% after winning a $9.5M grant for clinical investigation of MT-601 in pancreatic cancer patients.

MRKR

Read more →
Published at

Nov 26, 2024 6:00 PM

by gurufocus.com

neutral

neutral

Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

HOUSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. ( MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation

MRKR

Read more →
Published at

Nov 14, 2024 11:08 PM

by investing.com

mixed

mixed

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates By Investing.com

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

MRKR MLMAD.PA MLAHC.PA MLWEL.PA MLKRI.PA

Read more →
Published at

Oct 21, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in...

SPPI MCRB JNJ IGMS DJNJ3.BA DJNJ2.BA OMER MRKR KYKOF INCY INAB I1NC34.SA GILDD.BA DTIL APTO APS.TO 600276.SS 4151.T 0KBU.L 0J9P.L ADAG

Read more →
Published at

Aug 12, 2024 4:55 PM

by seekingalpha.com

positive

positive

Marker Therapeutics gets $2M NIH grant for MT-601 Phase 1 study (NASDAQ:MRKR)

Marker Therapeutics (MRKR) has been awarded a $2M NIH grant to support a Phase 1 study of its drug candidate MT-601 in the treatment of non-Hodgkin’s lymphoma. Read more here.

MRKR

Read more →
Published at

Aug 12, 2024 1:00 PM

by globenewswire.com

positive

positive

Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma

Marker Therapeutics to receive non-dilutive funding from NIH Small Business Innovation Research Program based on preliminary clinical results and...

MRKR

Read more →
Published at

Jul 29, 2024 7:00 PM

by globenewswire.com

mixed

mixed

IDH Inhibitor Market to Exhibit Significant Growth Rate During the Study Period (2020–2034) | DelveInsight

The IDH inhibitors market is expected to grow significantly in the coming years. This is due to the rising occurrence of IDH-mutated cancers, such as acute...

STTK PGEN NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF MRKR LLY.MX LLY.DE LLY.BA LLY LILY34.SA KPTI BPTH 0TDD.L 0Q1G.L NXTC KURA INCY INAB IMU.DE IMGN I1NC34.SA GILDD.BA CYAD APTO APS.TO ALPMY ALPMF 4503N.MX 0QFK.L 0J9P.L

Read more →
Published at

Apr 30, 2024 1:16 PM

by investing.com

positive

positive

Marker Therapeutics stock gets Buy from Ladenburg citing CAR-T therapy potential By Investing.com

Marker Therapeutics stock gets Buy from Ladenburg citing CAR-T therapy potential

MRKR

Read more →
Published at

Dec 12, 2023 1:04 PM

by rttnews.com

mixed

mixed

Pre-market Movers: JTAIZ, ICVX, CNTB, INAB, ADCT…

Jet.AI Inc. (JTAIZ) is up over 145% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..

ORCL.MX ORCL.BA ORCL ORC.DE ADCT PSTX MRKR INAB ICVX HMYN.MX HMY.BA HMY HGMCF HAR.JO CNTB CMNDF CMND.CN BITF.V BITF BFARF ACXP

Read more →
Published at

Dec 12, 2023 1:04 PM

by rttnews.com

mixed

mixed

Pre-market Movers: JTAIZ, ICVX, CNTB, INAB, ADCT…

Jet.AI Inc. (JTAIZ) is up over 145% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..

ORCL.MX ORCL.BA ORCL ORC.DE ADCT PSTX MRKR INAB ICVX HMYN.MX HMY.BA HMY HGMCF HAR.JO CNTB CMNDF CMND.CN BITF.V BITF BFARF ACXP

Read more →
Published at

Aug 7, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli

The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...

STTK PGEN NXTC NOXOF NOX.AX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA KPTI IMU.DE IMGN GILDD.BA CYAD CCCC BPTH APTO APS.TO ALPMY ALPMF 4503N.MX 0QFK.L 0Q1G.L TKBIF TCON NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF MRKR KURA INCY INAB I1NC34.SA 688336.SS 4974.T 0TDD.L 0J9P.L

Read more →
Published at

Jun 12, 2023 8:54 PM

by benzinga.com

positive

positive

Nasdaq Gains 1%; US Budget Deficit Widens In May - Allego (NYSE:ALLG), Asset Entities (NASDAQ:ASST)

U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500, also rose, gaining, 0.47% to 4,319.22.

VRM.MX VRM ONCR MRKR KDNY HTIA DHCNL DHC

Read more →